These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26491291)

  • 1. pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.
    Yao Y; Su Z; Liang Y; Zhang N
    Int J Nanomedicine; 2015; 10():6185-97. PubMed ID: 26491291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma.
    Yao Y; Wang T; Liu Y; Zhang N
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1374-1383. PubMed ID: 30977418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy.
    Sun W; Wang Y; Cai M; Lin L; Chen X; Cao Z; Zhu K; Shuai X
    Biomater Sci; 2017 Nov; 5(12):2468-2479. PubMed ID: 29106433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome.
    Zhao M; Lee SH; Song JG; Kim HY; Han HK
    Int J Pharm; 2018 Jun; 544(1):14-20. PubMed ID: 29655795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery.
    Li P; Liu D; Miao L; Liu C; Sun X; Liu Y; Zhang N
    Int J Nanomedicine; 2012; 7():925-39. PubMed ID: 22393290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
    Zhao R; Li T; Zheng G; Jiang K; Fan L; Shao J
    Biomaterials; 2017 Oct; 143():1-16. PubMed ID: 28755539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramide-Fabricated Co-Loaded Liposomes for the Synergistic Treatment of Hepatocellular Carcinoma.
    Yin X; Xiao Y; Han L; Zhang B; Wang T; Su Z; Zhang N
    AAPS PharmSciTech; 2018 Jul; 19(5):2133-2143. PubMed ID: 29714002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment.
    Xiao Y; Liu Y; Yang S; Zhang B; Wang T; Jiang D; Zhang J; Yu D; Zhang N
    Colloids Surf B Biointerfaces; 2016 May; 141():83-92. PubMed ID: 26844644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid
    Li W; Yan R; Liu Y; He C; Zhang X; Lu Y; Khan MW; Xu C; Yang T; Xiang G
    Drug Deliv; 2019 Dec; 26(1):794-802. PubMed ID: 31366257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy.
    Wang T; Zhang J; Hou T; Yin X; Zhang N
    Nanoscale; 2019 Aug; 11(29):13934-13946. PubMed ID: 31305839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy.
    Zheng G; Zhao R; Xu A; Shen Z; Chen X; Shao J
    Eur J Pharm Sci; 2018 Jan; 111():492-502. PubMed ID: 29107835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
    Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
    Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved anti-hepatocellular carcinoma effect by enhanced Co-delivery of Tim-3 siRNA and sorafenib via multiple pH triggered drug-eluting nanoparticles.
    Song C; Zhang J; Wen R; Li Q; Zhou J; Xiaoli Liu ; Wu Z; Lv Y; Wu R
    Mater Today Bio; 2022 Dec; 16():100350. PubMed ID: 35856043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA.
    Elzeny H; Zhang F; Ali EN; Fathi HA; Zhang S; Li R; El-Mokhtar MA; Hamad MA; Wooley KL; Elsabahy M
    Drug Des Devel Ther; 2017; 11():483-496. PubMed ID: 28260861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel.
    Liu F; Feng L; Zhang L; Zhang X; Zhang N
    Int J Pharm; 2013 Jul; 451(1-2):41-9. PubMed ID: 23608199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the potential of a simplified co-delivery system with oligodeoxynucleotides as a drug carrier for enhanced antitumor effect.
    Liu C; Liu T; Liu Y; Zhang N
    Int J Nanomedicine; 2018; 13():2435-2445. PubMed ID: 29719392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducing sustained release and improving oral bioavailability of curcumin via chitosan derivatives-coated liposomes.
    Tian MP; Song RX; Wang T; Sun MJ; Liu Y; Chen XG
    Int J Biol Macromol; 2018 Dec; 120(Pt A):702-710. PubMed ID: 30170061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codelivery of paclitaxel and small interfering RNA by octadecyl quaternized carboxymethyl chitosan-modified cationic liposome for combined cancer therapy.
    Zhang R; Wang SB; Chen AZ; Chen WG; Liu YG; Wu WG; Kang YQ; Ye SF
    J Biomater Appl; 2015 Sep; 30(3):351-60. PubMed ID: 25838353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective Skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes.
    Jose A; Labala S; Ninave KM; Gade SK; Venuganti VVK
    AAPS PharmSciTech; 2018 Jan; 19(1):166-175. PubMed ID: 28639178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.